AzTrials
AzTrials

Labor PainNCT04234178

Dural Puncture Epidural Versus Combined Spinal Epidural With Epidural Volume Extension in Labor Analgesia

A study testing Epidural and Intrathecal+Epidural in people with Labor Pain, run by Ataturk University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Labor is the process where the cervix is prepared to allow the baby to pass from the uterine cavity to the outside world. In the ordinary course, it ends with spontaneous or instrumental vaginal delivery or cesarean section. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Labor Pain
What is being tested?
Epidural and Intrathecal+Epidural
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Feb 2020to 7 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • ASA I and II parturients
  • Pregnant patients in active labor
  • active labor with cervical dilation < 5cm
  • 37-42 weeks of gestational age
  • Pregnant women between the ages of 18 and 45

Who cannot join

  • Patients who do not want to participate voluntarily in the study
  • Pregnant women outside the age range of 18 - 45
  • Pregnants other than Nullipar
  • Patients with allergic reactions to anesthesia and analgesia drugs to be used
  • Severe systemic disease (kidney, liver, pulmonary, endocrine, cardiac)
  • Gestational comorbidity (preeclampsia, eclampsia, diabetes mellitus, etc.)
Show all 11Show fewer
  • Substance abuse history
  • Chronic pain history
  • Psychiatric problems and communication difficulties
  • BMI> 35 kg / m2
  • Failure in neuraxial interventions

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Ataturk University

    Erzurum, Yakutiye, 25100

  • Erzurum Regional Training Research Hospital

    Erzurum, Yakutiye, 25100

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of Dural Puncture Epidural Versus Combined Spinal Epidural With Epidural Volume Extension Techniques on Birth Variables in Labor Analgesia

Labor is the process where the cervix is prepared to allow the baby to pass from the uterine cavity to the outside world. In the ordinary course, it ends with spontaneous or instrumental vaginal delivery or cesarean section. Traditionally, the first stage in which the cervix is passively dilated in response to uterine contractions consists of the second stage in which the mother passes the baby through the vagina and the third stage, the exit of the placenta.

In the first stage of labor, pain is caused by uterine contractions and pressure on the cervix. Pain is transmitted through the T10-L2 spinal nerves and is felt in the abdominal wall, waist, hips, or thighs. In the second stage, pain from the vagina and perineum is added to uterine pain. This pain is transmitted by the pudendal nerves through the S2-4 nerve roots.

In this study, we aimed to investigate the effects of dural puncture epidural analgesia versus combined spinal-epidural analgesia with epidural volume extension on labor variables.

Conditions
Labor Pain
Being tested
Epidural, Intrathecal+Epidural
Medical subject headings
Labor Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EpiduralDrug

    2 µg/ml fentanyl + %0,125 bupivacaine (20 ml) to epidural

  • Intrathecal+EpiduralDrug

    10 µg fentanyl + 2 mg bupivacaine to intrathecal 7.4 ml saline volume to epidural

Study groups in NCT04234178
Study groupRoleWhat they receive
Dural puncture epiduralActive comparator2 µg/ml fentanyl + %0,125 bupivacaine (20 ml) to epidural
Receives: Drug: Epidural
Combined spinal-epidural with epidural volume extensionActive comparator10 µg fentanyl + 2 mg bupivacaine to intrathecal 7.4 ml saline volume to epidural
Receives: Drug: Intrathecal+Epidural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First Epidural top-up time

    Time elapsed between the end of local anesthetic injection and the return of pain >4 on the NPRS.

    Measured: First 24 hours

Secondary outcomes (3)
  1. Sacral analgesia time

    Blockade of the S2 dermatome

    Measured: First 24 hours

  2. Performance time

    interval between skin disinfection and epidural catheter fixation to the skin

    Measured: First 24 hours

  3. Incidence of Side Effect

    maternal motor block, hypotension, pruritis, headache and fetal bradycardia

    Measured: First 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jan 2020
  2. Study start1 Feb 2020
  3. Primary completion1 Feb 2021
  4. Study completion7 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04234178
Sponsor's protocol ID
ATATURKLABOR
Status last verified
Feb 2022
First submitted
16 Jan 2020
Last updated
8 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Contreras F, Morales J, Bravo D, Layera S, Jara A, Riano C, Pizarro R, De La Fuente N, Aliste J, Finlayson RJ, Tran DQ. Dural puncture epidural analgesia for labor: a randomized comparison between 25-gauge and 27-gauge pencil point spinal needles. Reg Anesth Pain Med. 2019 May 22:rapm-2019-100608. doi: 10.1136/rapm-2019-100608. Online ahead of print.

    PubMed 31118278
  • Chau A, Bibbo C, Huang CC, Elterman KG, Cappiello EC, Robinson JN, Tsen LC. Dural Puncture Epidural Technique Improves Labor Analgesia Quality With Fewer Side Effects Compared With Epidural and Combined Spinal Epidural Techniques: A Randomized Clinical Trial. Anesth Analg. 2017 Feb;124(2):560-569. doi: 10.1213/ANE.0000000000001798.

    PubMed 28067707
  • Doymus O, Aydin ME, Bedir Z, Tor IH, Ejder Tekgunduz S, Doymus G, Celik EC, Ahiskalioglu A. Epidural volume extension versus dural puncture epidural analgesia for labor: A prospective randomized study. Medicine (Baltimore). 2025 Mar 7;104(10):e41691. doi: 10.1097/MD.0000000000041691.

    PubMed 40068075

Questions about this trial

What is this clinical trial studying?

A study testing Epidural and Intrathecal+Epidural in people with Labor Pain, run by Ataturk University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First Epidural top-up time (time frame: First 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04234178, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in